Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LZWL02003, an anti-neuroinflammatory agent, demonstrates a protective effect on MPP+-induced neuronal damage and reduces ROS expression. Additionally, it enhances cognition, memory, learning, and athleticism in Rotenone-induced Parkinson's disease (PD) rat models, suggesting its potential for neurodegenerative disease research [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約 35 days | ¥ 32,000 |
10 mg | 約 35 days | ¥ 50,000 |
25 mg | 約 35 days | ¥ 114,000 |
説明 | LZWL02003, an anti-neuroinflammatory agent, demonstrates a protective effect on MPP+-induced neuronal damage and reduces ROS expression. Additionally, it enhances cognition, memory, learning, and athleticism in Rotenone-induced Parkinson's disease (PD) rat models, suggesting its potential for neurodegenerative disease research [1]. |
分子量 | 294.35 |
分子式 | C18H18N2O2 |
CAS No. | 1371564-45-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LZWL02003 1371564-45-2 Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species Inhibitor inhibitor inhibit